Details for: PRDM1

Gene ID: 639

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: PRDM1

Ensembl ID: ENSG00000057657

Description: PR/SET domain 1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • stem cell CL0000034
    CSI 33.01
    rCSI 31.83%
    PRS 44.95
  • plasma cell CL0000786
    CSI 29.15
    rCSI 38.21%
    PRS 83.63
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 20.01
    rCSI 26.22%
    PRS 67.93
  • plasmablast CL0000980
    CSI 17.69
    rCSI 13.92%
    PRS 61.16
  • IgG plasma cell CL0000985
    CSI 13.87
    rCSI 16.61%
    PRS 72.7
  • conjunctival epithelial cell CL1000432
    CSI 13.5
    rCSI 20.62%
    PRS 55.09
  • vascular associated smooth muscle cell CL0000359
    CSI 12.61
    rCSI 40.89%
    PRS 55.96
  • stromal cell CL0000499
    CSI 12.28
    rCSI 34.55%
    PRS 52.17
  • mature T cell CL0002419
    CSI 11.87
    rCSI 9.23%
    PRS 72.24
  • T follicular helper cell CL0002038
    CSI 11.53
    rCSI 8.63%
    PRS 69.69
  • IgA plasma cell CL0000987
    CSI 9.67
    rCSI 9.9%
    PRS 70.85
  • lung pericyte CL0009089
    CSI 8.96
    rCSI 23.64%
    PRS 62.96
  • myeloid leukocyte CL0000766
    CSI 8.19
    rCSI 7.56%
    PRS 55.59
  • Hofbauer cell CL3000001
    CSI 7.71
    rCSI 14.55%
    PRS 64.84
  • helper T cell CL0000912
    CSI 7.67
    rCSI 10.85%
    PRS 61.03
  • erythrocyte CL0000232
    CSI 7.56
    rCSI 17.16%
    PRS 59.57
  • activated type II NK T cell CL0000931
    CSI 7.26
    rCSI 8.17%
    PRS 70.93
  • neural progenitor cell CL0011020
    CSI 6.7
    rCSI 29.48%
    PRS 46.06
  • mature NK T cell CL0000814
    CSI 6.63
    rCSI 8.48%
    PRS 79.71
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 6.61
    rCSI 9.09%
    PRS 74.6
  • alpha-beta T cell CL0000789
    CSI 6.24
    rCSI 7.31%
    PRS 70.7
  • colon macrophage CL0009038
    CSI 6.17
    rCSI 28.5%
    PRS 74.66
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 6.13
    rCSI 7.62%
    PRS 35.32
  • regulatory T cell CL0000815
    CSI 5.47
    rCSI 6.34%
    PRS 68.95
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 4.86
    rCSI 9.69%
    PRS 72.69
  • squamous epithelial cell CL0000076
    CSI 4.71
    rCSI 11.17%
    PRS 59.2
  • naive T cell CL0000898
    CSI 4.45
    rCSI 3.1%
    PRS 68.7
  • cerebral cortex endothelial cell CL1001602
    CSI 4.26
    rCSI 7.38%
    PRS 44.61
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 4.16
    rCSI 10.75%
    PRS 81.93
  • CD4-positive helper T cell CL0000492
    CSI 4
    rCSI 3.02%
    PRS 68.08
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 3.96
    rCSI 4.13%
    PRS 79.19
  • blood vessel endothelial cell CL0000071
    CSI 3.9
    rCSI 8.1%
    PRS 51.68
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 3.71
    rCSI 2.47%
    PRS 76.73
  • pulmonary capillary endothelial cell CL4028001
    CSI 3.24
    rCSI 6.17%
    PRS 70.23
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 3.1
    rCSI 2.22%
    PRS 68.37
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 2.95
    rCSI 2.24%
    PRS 67.06
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.94
    rCSI 3.52%
    PRS 74.42
  • alternatively activated macrophage CL0000890
    CSI 2.9
    rCSI 3.64%
    PRS 67.22
  • mononuclear phagocyte CL0000113
    CSI 2.88
    rCSI 6.35%
    PRS 58.27
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 2.88
    rCSI 2.66%
    PRS 74.53
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 2.79
    rCSI 7.27%
    PRS 53.64
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 2.73
    rCSI 2.68%
    PRS 78.01
  • double negative thymocyte CL0002489
    CSI 2.65
    rCSI 1.84%
    PRS 64.77
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.64
    rCSI 1.56%
    PRS 71.22
  • lung interstitial macrophage CL4033043
    CSI 2.58
    rCSI 5.78%
    PRS 72.87
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.57
    rCSI 2.52%
    PRS 70.26
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 2.56
    rCSI 2.33%
    PRS 68.71
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 2.54
    rCSI 3.96%
    PRS 79.85
  • perivascular cell CL4033054
    CSI 2.39
    rCSI 3.27%
    PRS 60
  • natural T-regulatory cell CL0000903
    CSI 2.38
    rCSI 4.51%
    PRS 85.18
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.01
    rCSI 3.2%
    PRS 58.24
  • bronchus fibroblast of lung CL2000093
    CSI 1.95
    rCSI 1.59%
    PRS 54.79
  • lung macrophage CL1001603
    CSI 1.94
    rCSI 4.33%
    PRS 61.81
  • sst GABAergic cortical interneuron CL4023017
    CSI 1.93
    rCSI 2.48%
    PRS 38.17
  • colon epithelial cell CL0011108
    CSI 1.91
    rCSI 2%
    PRS 51.18
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.88
    rCSI 2.27%
    PRS 62.84
  • vein endothelial cell of respiratory system CL4033008
    CSI 1.88
    rCSI 12.89%
    PRS 69.48
  • intermediate monocyte CL0002393
    CSI 1.87
    rCSI 2.82%
    PRS 57.53
  • T-helper 17 cell CL0000899
    CSI 1.86
    rCSI 1.48%
    PRS 76.51
  • mature alpha-beta T cell CL0000791
    CSI 1.84
    rCSI 6.64%
    PRS 74.22
  • class switched memory B cell CL0000972
    CSI 1.75
    rCSI 1.3%
    PRS 72.21
  • hepatic pit cell CL2000054
    CSI 1.74
    rCSI 23.8%
    PRS 84.1
  • pancreatic stellate cell CL0002410
    CSI 1.69
    rCSI 9.84%
    PRS 64.34
  • inflammatory macrophage CL0000863
    CSI 1.66
    rCSI 2.84%
    PRS 79.3
  • dendritic cell, human CL0001056
    CSI 1.62
    rCSI 2.48%
    PRS 62.75
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 1.59
    rCSI 4.56%
    PRS 73.78
  • retinal cone cell CL0000573
    CSI 1.56
    rCSI 2.51%
    PRS 44.4
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 1.4
    rCSI 1.91%
    PRS 80.07
  • myeloid dendritic cell CL0000782
    CSI 1.35
    rCSI 1.96%
    PRS 70.48
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 1.32
    rCSI 0.89%
    PRS 66.79
  • intraepithelial lymphocyte CL0002496
    CSI 1.31
    rCSI 3.55%
    PRS 85.79
  • intestinal epithelial cell CL0002563
    CSI 1.3
    rCSI 1.36%
    PRS 53.08
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 1.3
    rCSI 3.13%
    PRS 87.86
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 1.21
    rCSI 1.47%
    PRS 44.59
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 1.21
    rCSI 2.07%
    PRS 73.6
  • elicited macrophage CL0000861
    CSI 1.18
    rCSI 1.08%
    PRS 62.78
  • nasal mucosa goblet cell CL0002480
    CSI 1.15
    rCSI 1.34%
    PRS 63.3
  • uterine smooth muscle cell CL0002601
    CSI 1.15
    rCSI 7.58%
    PRS 79.3
  • Langerhans cell CL0000453
    CSI 1.1
    rCSI 1.68%
    PRS 71.17
  • innate lymphoid cell CL0001065
    CSI 0.88
    rCSI 1.82%
    PRS 57.66
  • fibroblast of breast CL4006000
    CSI 0.88
    rCSI 3.7%
    PRS 70.63
  • endothelial cell of uterus CL0009095
    CSI 0.85
    rCSI 6.24%
    PRS 74.35
  • antibody secreting cell CL0000946
    CSI 0.74
    rCSI 3.3%
    PRS 89.36
  • BEST4+ enteroycte CL4030026
    CSI 0.68
    rCSI 0.84%
    PRS 56.51
  • IgM plasma cell CL0000986
    CSI 0.67
    rCSI 3.01%
    PRS 87.8
  • GABAergic neuron CL0000617
    CSI 0.55
    rCSI 1.83%
    PRS 40.65
  • endothelial cell of placenta CL0009092
    CSI 0.53
    rCSI 2.6%
    PRS 65.83
  • type EC enteroendocrine cell CL0000577
    CSI 0.49
    rCSI 1.75%
    PRS 64.98
  • memory T cell CL0000813
    CSI 0.49
    rCSI 0.95%
    PRS 81.8
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.48
    rCSI 2.39%
    PRS 66.79
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.31
    rCSI 7.31%
    PRS 75.91
  • epithelial cell of esophagus CL0002252
    CSI 0.29
    rCSI 2.9%
    PRS 75.4
  • cytotoxic T cell CL0000910
    CSI 0.19
    rCSI 1.06%
    PRS 64.94

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [PRDM1](/details-gene/639) (PR/SET domain 1), also known as Blimp-1, is a protein-coding gene on chromosome 6q21 that encodes a zinc finger-containing transcriptional repressor. It functions as a master regulator of cell fate commitment, particularly in the immune system and during embryonic development. **Overall**, [PRDM1](/details-gene/639) shows its highest significance in terminally differentiated B lymphocytes, such as the [plasma cell](/details-cell/CL0000786) and [plasmablast](/details-cell/CL0000980), where it is essential for driving the differentiation process and initiating antibody secretion. Its function is primarily mediated through its [Dna-binding transcription repressor activity, rna polymerase ii-specific](/details-go/GO:0001227), silencing genes associated with the progenitor state. Beyond the B cell lineage, it also displays notable significance in [stem cell](/details-cell/CL0000034) populations and various myeloid and T cell subsets, suggesting a broad role in hematopoietic lineage determination and immune regulation. ## Cellular Roles and Expression Landscape The expression profile of [PRDM1](/details-gene/639) underscores its critical role in the terminal differentiation of the B lymphocyte lineage. **Overall**, it is most significant in [plasma cell](/details-cell/CL0000786) (CSI: 29.15), [plasmablast](/details-cell/CL0000980) (CSI: 17.69), [IgG plasma cell](/details-cell/CL0000985) (CSI: 13.87), and [IgA plasma cell](/details-cell/CL0000987) (CSI: 9.67). This is consistent with its established function as a master regulator that extinguishes the B cell genetic program and initiates the machinery for high-rate antibody production, a process critically dependent on post-translational modifications like SUMOylation ([Link](https://doi.org/10.1038/embor.2012.60)). Beyond its quintessential role in B cells, [PRDM1](/details-gene/639) exhibits high significance in [stem cell](/details-cell/CL0000034) populations (CSI: 33.01), implicating it in early developmental decisions and pluripotency, particularly in the context of [Germ cell development](/details-go/GO:0007281) ([Link](https://doi.org/10.1093/hmg/ddr114)). Its expression is also significant in subsets of both the innate and adaptive immune systems, including [CD14-positive, CD16-positive monocyte](/details-cell/CL0002397) (CSI: 20.01), [mature T cell](/details-cell/CL0002419) (CSI: 11.87), and [T follicular helper cell](/details-cell/CL0002038) (CSI: 11.53). This suggests that [PRDM1](/details-gene/639) may play analogous roles in orchestrating terminal differentiation or regulating effector functions across multiple hematopoietic lineages. ## Pathways and Molecular Function [PRDM1](/details-gene/639) functions as a sequence-specific transcription factor that primarily represses gene expression. Its molecular function is defined by its [Dna-binding transcription repressor activity, rna polymerase ii-specific](/details-go/GO:0001227) and its ability to recruit chromatin-modifying enzymes. This activity drives key biological processes, most notably the [Adaptive immune response](/details-go/GO:0002250) and [Innate immune response](/details-go/GO:0045087), by controlling the differentiation of key immune effectors. The gene is integral to fundamental cellular machinery pathways such as [Gene expression (transcription)](/details-reactome/R-HSA-74160) and [Rna polymerase ii transcription](/details-reactome/R-HSA-73857). Its developmental roles are highlighted by its involvement in pathways like [Specification of primordial germ cells](/details-reactome/R-HSA-9827857) and numerous developmental processes annotated in Gene Ontology, including [Aorta development](/details-go/GO:0035904) and [Kidney development](/details-go/GO:0001822). Additionally, its participation in the [Regulation of tp53 expression and degradation](/details-reactome/R-HSA-6806003) pathway suggests a role in cell cycle control and tumor suppression, which is consistent with its known dysregulation in various cancers, including myeloma ([Link](https://doi.org/10.4049/jimmunol.170.6.3125)). ## Research Directions Dysregulation of [PRDM1](/details-gene/639) is a hallmark of several hematological malignancies. For instance, functional impairment or loss of [PRDM1](/details-gene/639) is associated with certain types of lymphoma, whereas its continued expression is essential for the survival of multiple myeloma cells, highlighting its context-dependent role as both a tumor suppressor and a lineage-survival factor. Based on its expression profile and functional annotations, several testable hypotheses can be proposed: 1. **Hypothesis:** [PRDM1](/details-gene/639) orchestrates a convergent terminal differentiation program in both antibody-secreting [plasma cell](/details-cell/CL0000786) and effector T cells by repressing a common set of genes associated with lymphocyte proliferation and multipotency. 2. **Hypothesis:** In [CD14-positive, CD16-positive monocyte](/details-cell/CL0002397), [PRDM1](/details-gene/639) functions to limit inflammatory responses by directly repressing the promoters of key pro-inflammatory cytokine genes, thereby acting as a crucial checkpoint for innate immune activation. 3. **Hypothesis:** The role of [PRDM1](/details-gene/639) in regulating TP53 pathways is critical for preventing oncogenic transformation during the highly proliferative plasmablast stage of B cell differentiation. To test the second hypothesis regarding the role of [PRDM1](/details-gene/639) in monocytes, a compelling experiment would be to use CRISPR-Cas9 to knock out [PRDM1](/details-gene/639) in primary human monocytes. These engineered cells and their wild-type counterparts could then be stimulated with lipopolysaccharide (LPS). Subsequent RNA-sequencing would reveal global changes in the inflammatory transcriptome, while cytokine assays (ELISA) would quantify functional differences in protein secretion. Chromatin immunoprecipitation sequencing (ChIP-seq) for PRDM1 in stimulated monocytes could then be used to identify its direct genomic targets, confirming whether it binds to the promoters of key inflammatory genes. Therapeutically, [PRDM1](/details-gene/639) presents a complex target. As an intracellular transcription factor, it is difficult to target directly with small molecules. In malignancies where its loss is oncogenic (e.g., some lymphomas), a therapeutic strategy could involve restoring its function, potentially via epigenetic drugs that de-repress its expression. Conversely, in cancers dependent on its activity, such as multiple myeloma, the strategy would be inhibition. This might be more feasibly achieved by targeting its critical downstream effectors or upstream regulators rather than [PRDM1](/details-gene/639) itself.

Genular Protein ID: 4161602001

Symbol: PRDM1_HUMAN

Name: PR domain zinc finger protein 1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 1851123

Title: Identification and characterization of a novel repressor of beta-interferon gene expression.

PubMed ID: 1851123

DOI: 10.1101/gad.5.5.868

PubMed ID: 12626569

Title: Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.

PubMed ID: 12626569

DOI: 10.4049/jimmunol.170.6.3125

PubMed ID: 14574404

Title: The DNA sequence and analysis of human chromosome 6.

PubMed ID: 14574404

DOI: 10.1038/nature02055

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 21421998

Title: NANOS3 function in human germ cell development.

PubMed ID: 21421998

DOI: 10.1093/hmg/ddr114

PubMed ID: 22555612

Title: SUMOylation of Blimp-1 is critical for plasma cell differentiation.

PubMed ID: 22555612

DOI: 10.1038/embor.2012.60

PubMed ID: 24613396

Title: DRE-1/FBXO11-dependent degradation of BLMP-1/BLIMP-1 governs C. elegans developmental timing and maturation.

PubMed ID: 24613396

DOI: 10.1016/j.devcel.2014.01.028

PubMed ID: 24968003

Title: BLMP-1/Blimp-1 regulates the spatiotemporal cell migration pattern in C. elegans.

PubMed ID: 24968003

DOI: 10.1371/journal.pgen.1004428

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

PubMed ID: 32417234

Title: LDB1 and the SWI/SNF complex participate in both transcriptional activation and repression by Caenorhabditis elegans BLIMP1/PRDM1.

PubMed ID: 32417234

DOI: 10.1016/j.bbagrm.2020.194577

PubMed ID: 28842558

Title: HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.

PubMed ID: 28842558

DOI: 10.1038/s41467-017-00476-w

Sequence Information:

  • Length: 825
  • Mass: 91771
  • Checksum: 07B389BACCD6172F
  • Sequence:
  • MLDICLEKRV GTTLAAPKCN SSTVRFQGLA EGTKGTMKMD MEDADMTLWT EAEFEEKCTY 
    IVNDHPWDSG ADGGTSVQAE ASLPRNLLFK YATNSEEVIG VMSKEYIPKG TRFGPLIGEI 
    YTNDTVPKNA NRKYFWRIYS RGELHHFIDG FNEEKSNWMR YVNPAHSPRE QNLAACQNGM 
    NIYFYTIKPI PANQELLVWY CRDFAERLHY PYPGELTMMN LTQTQSSLKQ PSTEKNELCP 
    KNVPKREYSV KEILKLDSNP SKGKDLYRSN ISPLTSEKDL DDFRRRGSPE MPFYPRVVYP 
    IRAPLPEDFL KASLAYGIER PTYITRSPIP SSTTPSPSAR SSPDQSLKSS SPHSSPGNTV 
    SPVGPGSQEH RDSYAYLNAS YGTEGLGSYP GYAPLPHLPP AFIPSYNAHY PKFLLPPYGM 
    NCNGLSAVSS MNGINNFGLF PRLCPVYSNL LGGGSLPHPM LNPTSLPSSL PSDGARRLLQ 
    PEHPREVLVP APHSAFSFTG AAASMKDKAC SPTSGSPTAG TAATAEHVVQ PKATSAAMAA 
    PSSDEAMNLI KNKRNMTGYK TLPYPLKKQN GKIKYECNVC AKTFGQLSNL KVHLRVHSGE 
    RPFKCQTCNK GFTQLAHLQK HYLVHTGEKP HECQVCHKRF SSTSNLKTHL RLHSGEKPYQ 
    CKVCPAKFTQ FVHLKLHKRL HTRERPHKCS QCHKNYIHLC SLKVHLKGNC AAAPAPGLPL 
    EDLTRINEEI EKFDISDNAD RLEDVEDDIS VISVVEKEIL AVVRKEKEET GLKVSLQRNM 
    GNGLLSSGCS LYESSDLPLM KLPPSNPLPL VPVKVKQETV EPMDP

Genular Protein ID: 3231884389

Symbol: Q5T4E8_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11181995

Title: The sequence of the human genome.

PubMed ID: 11181995

DOI: 10.1126/science.1058040

Sequence Information:

  • Length: 789
  • Mass: 87991
  • Checksum: 6A1FEBEAD309BC7D
  • Sequence:
  • MKMDMEDADM TLWTEAEFEE KCTYIVNDHP WDSGADGGTS VQAEASLPRN LLFKYATNSE 
    EVIGVMSKEY IPKGTRFGPL IGEIYTNDTV PKNANRKYFW RIYSRGELHH FIDGFNEEKS 
    NWMRYVNPAH SPREQNLAAC QNGMNIYFYT IKPIPANQEL LVWYCRDFAE RLHYPYPGEL 
    TMMNLTQTQS SLKQPSTEKN ELCPKNVPKR EYSVKEILKL DSNPSKGKDL YRSNISPLTS 
    EKDLDDFRRR GSPEMPFYPR VVYPIRAPLP EDFLKASLAY GIERPTYITR SPIPSSTTPS 
    PSARSSPDQS LKSSSPHSSP GNTVSPVGPG SQEHRDSYAY LNASYGTEGL GSYPGYAPLP 
    HLPPAFIPSY NAHYPKFLLP PYGMNCNGLS AVSSMNGINN FGLFPRLCPV YSNLLGGGSL 
    PHPMLNPTSL PSSLPSDGAR RLLQPEHPRE VLVPAPHSAF SFTGAAASMK DKACSPTSGS 
    PTAGTAATAE HVVQPKATSA AMAAPSSDEA MNLIKNKRNM TGYKTLPYPL KKQNGKIKYE 
    CNVCAKTFGQ LSNLKVHLRV HSGERPFKCQ TCNKGFTQLA HLQKHYLVHT GEKPHECQVC 
    HKRFSSTSNL KTHLRLHSGE KPYQCKVCPA KFTQFVHLKL HKRLHTRERP HKCSQCHKNY 
    IHLCSLKVHL KGNCAAAPAP GLPLEDLTRI NEEIEKFDIS DNADRLEDVE DDISVISVVE 
    KEILAVVRKE KEETGLKVSL QRNMGNGLLS SGCSLYESSD LPLMKLPPSN PLPLVPVKVK 
    QETVEPMDP

Genular Protein ID: 1467833650

Symbol: B4DW27_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 629
  • Mass: 70046
  • Checksum: 17E63BE19CC57AE7
  • Sequence:
  • MEKIYSRGEL HHFIDGFNEE KSNWMRYVNP AHSPREQNLA ACQNGMNIYF YTIKPIPANQ 
    ELLVWYCRDF AERLHYPYPG ELTMMNLTQT QSSLKQPSTE KNELCPKNVP KREYSVKEIL 
    KLDSNPSKGK DLYRSNISPL TSEKDLDDFR RRGSPEMPFY PRVVYPIRAP LPEDFLKASL 
    AYGIERPTYI TRSPIPSSTT PSPSARSSPD QSLKSSSPHS SPGNTVSPVG PGSQEHRDSY 
    AYLNASYGTE GLGSYPGYAP LPHLPPAFIP SYNAHYPKFL LPPYGMNCNG LSAVSSMNGI 
    NNFGLFPRLC PVYSNLLGGG SLPHPMLNPT SLPSSLPSDG ARRLLQPEHP REVLVPAPHS 
    AFSFTGAAAS MKDKACSPTS GSPTAGTAAT AEHVVQPKAT SAAMAAPSSD EAMNLIKNKR 
    NMTGYKTLPY PLKKQNGKIK YECNVCAKTF GQLSNLKVHL RVHSGERPFK CQTCNKGFTQ 
    LAHLQKHYLV HTGEKPHECQ VCHKRFSSTS NLKTHLRLHS GEKPYQCKVC PAKFTQFVHL 
    KLHKRLHTRE RPHKCSQCHK NYIHLCSLKV HLKGNCAAAP APGLPLEDLT RINEEIEKFD 
    ISDNADRLED VEDDISVISV VEKEILAVV

Genular Protein ID: 3327863494

Symbol: A0A3B3IU23_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 14574404

Title: The DNA sequence and analysis of human chromosome 6.

PubMed ID: 14574404

DOI: 10.1038/nature02055

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

Sequence Information:

  • Length: 839
  • Mass: 93296
  • Checksum: 8802B62F65B12C0A
  • Sequence:
  • MTPGILGHWT VCPEHFSAMR GKARDCSEAA PKCNSSTVRF QGLAEGTKGT MKMDMEDADM 
    TLWTEAEFEE KCTYIVNDHP WDSGADGGTS VQAEASLPRN LLFKYATNSE EVIGVMSKEY 
    IPKGTRFGPL IGEIYTNDTV PKNANRKYFW RIYSRGELHH FIDGFNEEKS NWMRYVNPAH 
    SPREQNLAAC QNGMNIYFYT IKPIPANQEL LVWYCRDFAE RLHYPYPGEL TMMNLTQTQS 
    SLKQPSTEKN ELCPKNVPKR EYSVKEILKL DSNPSKGKDL YRSNISPLTS EKDLDDFRRR 
    GSPEMPFYPR VVYPIRAPLP EDFLKASLAY GIERPTYITR SPIPSSTTPS PSARSSPDQS 
    LKSSSPHSSP GNTVSPVGPG SQEHRDSYAY LNASYGTEGL GSYPGYAPLP HLPPAFIPSY 
    NAHYPKFLLP PYGMNCNGLS AVSSMNGINN FGLFPRLCPV YSNLLGGGSL PHPMLNPTSL 
    PSSLPSDGAR RLLQPEHPRE VLVPAPHSAF SFTGAAASMK DKACSPTSGS PTAGTAATAE 
    HVVQPKATSA AMAAPSSDEA MNLIKNKRNM TGYKTLPYPL KKQNGKIKYE CNVCAKTFGQ 
    LSNLKVHLRV HSGERPFKCQ TCNKGFTQLA HLQKHYLVHT GEKPHECQVC HKRFSSTSNL 
    KTHLRLHSGE KPYQCKVCPA KFTQFVHLKL HKRLHTRERP HKCSQCHKNY IHLCSLKVHL 
    KGNCAAAPAP GLPLEDLTRI NEEIEKFDIS DNADRLEDVE DDISVISVVE KEILAVVRKE 
    KEETGLKVSL QRNMGNGLLS SGCSLYESSD LPLMKLPPSN PLPLVPVKVK QETVEPMDP